Cantor Fitzgerald Maintains Overweight on Elevance Health, Raises Price Target to $450

Benzinga Newsdesk www.benzinga.com Positive 53.9%

Neg 0% Neu 0% Pos 53.9%

Cantor Fitzgerald analyst Sarah James maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $400 to $450.